We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · November 08, 2021

No Efficacy Seen for Intranasal Oxytocin in Children/Adolescents With Autism Spectrum Disorder

The New England Journal of Medicine


Additional Info

The New England Journal of Medicine
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
N. Engl. J. Med 2021 Oct 14;385(16)1462-1473, L Sikich, A Kolevzon, BH King, CJ McDougle, KB Sanders, SJ Kim, M Spanos, T Chandrasekhar, MDP Trelles, CM Rockhill, ML Palumbo, A Witters Cundiff, A Montgomery, P Siper, M Minjarez, LA Nowinski, S Marler, LC Shuffrey, C Alderman, J Weissman, B Zappone, JE Mullett, H Crosson, N Hong, SK Siecinski, SN Giamberardino, S Luo, L She, M Bhapkar, R Dean, A Scheer, JL Johnson, SG Gregory, J Veenstra-VanderWeele

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading